Software driven biology for small molecule mRNA drugs

March 3rd, 2022

Biotech 2050 Podcast · 92. Software driven biology for small molecule mRNA drugs, Yochi Slonim, Co-founder & CEO, Anima

Our CEO, Yochi Slonim discusses his entrepreneurial journey, the genesis of Anima Biotech and how we combine high-scale phenotypic screening with AI mRNA image analysis to discover selective mRNA small molecule drugs and rapidly elucidate their mechanisms of action on the Biotech 2050 Podcast with Alok Tayi, Ph.D. and Rahul Chatuverdi. Each week, Biotech2050 brings in experts across biotech to learn more about how their work “disrupts” the industry and evokes change.